Key result
The management of anticoagulants during pregnancy requires balancing maternal thromboembolic risks and fetal embryopathy risks, with particular challenges remaining for women with mechanical heart valves.
No takes yet. Share an insight, caveat, or question.
The management of anticoagulants during pregnancy requires carefully balancing the fetal embryopathic risks of oral anticoagulants against the maternal thromboembolic and hemorrhagic risks of heparin, particularly in women with mechanical heart valves.
G Hanania (2001) conducted an editorial in Pregnancy with mechanical heart valves or coagulation anomalies. Anticoagulants was evaluated. The management of anticoagulants during pregnancy requires balancing maternal thromboembolic risks and fetal embryopathy risks, with particular challenges remaining for women with mechanical heart valves.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: